Need Help?

Whole-exome sequencing and microRNA profiling predicted relapse risk of stage I lung adenocarcinomas for the study and all the datasets.

This dataset contains CEL files and rma normalized expression value for microarray of stage I lung adenocarcinomas from Asian patients. In total, there are 69 patients and 138 samples, including 69 tumor samples and 69 adjacent normal samples.

Request Access

MSCTLCC data access agreement

DATA ACCESS AGREEMENT These terms and conditions govern access to the managed access datasets (details of which are set out in Appendix I) to which the User Institution has requested access. The User Institution agrees to be bound by these terms and conditions. Definitions Data refers to any and all human genetic, epigenetic or phenotype data obtained from through this agreement. Data Producers refer to the Mutational Study Committee of a Taiwanese Lung Cancer Cohort (hereinafter referred to as MSCTLCC) and the collaborators listed in Appendix I. Research Participant refers to an individual whose data form part of these Data. User Institution(s) refers to the institution that has requested access to these Data. Project refers to the project for which the User Institution has requested access to these Data. A description of the Project is set out in Appendix II. User refers to the principal investigator for the Project. Authorized Personnel refers to the individuals at the User Institution to whom MSCTLCC grants access to the Data. This includes the User, the individuals listed in Appendix II and any other individuals for whom the User Institution subsequently requests access to the Data. Details of the initial Authorized Personnel are set out in Appendix II. External Collaborator refers to a collaborator of the User, working for an institution other than the User Institution. Research Purposes shall mean research that is seeking to advance the understanding of genetics and genomics, including the treatment of disorders, and work on statistical methods that may be applied to such research. Publication(s) refers, without limitation, to any and all articles published in print journals, electronic journals, reviews, books, posters and other written and verbal presentations of research. 1. The User Institution agrees to only use these Data for the purpose of the Project (described in Appendix II) and only for Research Purposes. The User Institution further agrees that it will only use these Data for Research Purposes which are within the limitations (if any) set out in Appendix I. 2. The User Institution agrees to preserve, at all times, the confidentiality of these Data. In particular, it undertakes not to use, or attempt to use these Data to compromise or otherwise infringe the confidentiality of information on Research Participants. Without prejudice to the generality of the foregoing, the User Institution agrees to use at least the measures set out in Appendix I to protect these Data. 3. The User Institution agrees to protect the confidentiality of Research Participants in any research papers or publications that they prepare by taking all reasonable care to limit the possibility of identification. 4. The User Institution agrees not to link or combine these Data to other information or archived data available in a way that could re-identify the Research Participants, even if access to that data has been formally granted to the User Institution or is freely available without restriction. 5. The User Institution agrees only to transfer or disclose these Data, in whole or part, or any material derived from these Data, to the Authorized Personnel. Should the User Institution wish to share these Data with an External Collaborator, the External Collaborator must complete a separate application for access to these Data. 6. The User Institution agrees that the Data Producers, and all other parties involved in the creation, funding or protection of these Data: a) make no warranty or representation, express or implied as to the accuracy, quality or comprehensiveness of these Data; b) exclude to the fullest extent permitted by law all liability for actions, claims, proceedings, demands, losses (including but not limited to loss of profit), costs, awards damages and payments made by the Recipient that may arise (whether directly or indirectly) in any way whatsoever from the Recipient’s use of these Data or from the unavailability of, or break in access to, these Data for whatever reason and; c) bear no responsibility for the further analysis or interpretation of these Data. 7. The User Institution agrees to follow the Fort Lauderdale Guidelines (http://www.wellcome.ac.uk/stellent/groups/corporatesite/@policy_communications/documents/web_document/wtd003207.pdf ) and the Toronto Statement (http://www.nature.com/nature/journal/v461/n7261/full/461168a.html). This includes but is not limited to recognizing the contribution of the Data Producers and including a proper acknowledgement in all reports or publications resulting from the use of these Data. 8. The User Institution agrees to follow the Publication Policy in Appendix III. This includes respecting the moratorium period for the Data Producers to publish the first peer-reviewed report describing and analyzing these Data. 9. The User Institution agrees not to make intellectual property claims on these Data and not to use intellectual property protection in ways that would prevent or block access to, or use of, any element of these Data, or conclusion drawn directly from these Data. 10. The User Institution can elect to perform further research that would add intellectual and resource capital to these data and decide to obtain intellectual property rights on these downstream discoveries. In this case, the User Institution agrees to implement licensing policies that will not obstruct further research and to follow the U.S. National Institutes of Health Best Practices for the Licensing of Genomic Inventions (2005) (https://www.icgc.org/files/daco/NIH_BestPracticesLicensingGenomicInventions_2005_en.pdf ) in conformity with the Organisation for Economic Co-operation and Development Guidelines for the Licensing of the Genetic Inventions (2006) (http://www.oecd.org/science/biotech/36198812.pdf ). 11. The User Institution agrees to destroy/discard the Data held, once it is no longer used for the Project, unless obliged to retain the data for archival purposes in conformity with audit or legal requirements. 12. The User Institution will notify MSCTLCC within 30 days of any changes or departures of Authorized Personnel. 13. The User Institution will notify MSCTLCC prior to any significant changes to the protocol for the Project. 14. The User Institution will notify MSCTLCC as soon as it becomes aware of a breach of the terms or conditions of this agreement. 15. MSCTLCC may terminate this agreement by written notice to the User Institution. If this agreement terminates for any reason, the User Institution will be required to destroy any Data held, including copies and backup copies. This clause does not prevent the User Institution from retaining these data for archival purpose in conformity with audit or legal requirements. 16. The User Institution accepts that it may be necessary for the Data Producers to alter the terms of this agreement from time to time. As an example, this may include specific provisions relating to the Data required by Data Producers other than MSCTLCC. In the event that changes are required, the Data Producers or their appointed agent will contact the User Institution to inform it of the changes and the User Institution may elect to accept the changes or terminate the agreement. 17. If requested, the User Institution will allow data security and management documentation to be inspected to verify that it is complying with the terms of this agreement. 18. The User Institution agrees to distribute a copy of these terms to the Authorized Personnel. The User Institution will procure that the Authorized Personnel comply with the terms of this agreement. 19. The User Institution accepts that the Data is protected by and subject to international laws, including but not limited to the UK Data Protection Act 1998, and that The User Institution are responsible for ensuring compliance with any such applicable law. The Data Producers reserve the right to request and inspect data security and management documentation to ensure the adequacy of data protection measures in countries that have no national laws comparable to that which pertain in the EAA. 20. This agreement (and any dispute, controversy, proceedings or claim of whatever nature arising out of this agreement or its formation) shall be construed, interpreted and governed by the laws of England and Wales and shall be subject to the non-exclusive jurisdiction of the English courts.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS00001004461 Other

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Located in
EGAF00003952856 CEL 3.0 MB
EGAF00003952860 CEL 3.0 MB
EGAF00003952863 CEL 3.0 MB
EGAF00003952868 CEL 3.0 MB
EGAF00003952869 CEL 3.0 MB
EGAF00003952877 CEL 3.0 MB
EGAF00003952879 CEL 3.0 MB
EGAF00003952882 CEL 3.0 MB
EGAF00003952883 CEL 3.0 MB
EGAF00003952885 CEL 3.0 MB
EGAF00003952886 CEL 3.0 MB
EGAF00003952888 CEL 3.0 MB
EGAF00003952890 CEL 3.0 MB
EGAF00003952903 CEL 3.0 MB
EGAF00003952911 CEL 3.0 MB
EGAF00003952912 CEL 3.0 MB
EGAF00003952921 CEL 3.0 MB
EGAF00003952922 CEL 3.0 MB
EGAF00003952928 CEL 3.0 MB
EGAF00003952931 CEL 3.0 MB
EGAF00003952934 CEL 3.0 MB
EGAF00003952936 CEL 3.0 MB
EGAF00003952941 CEL 3.0 MB
EGAF00003952942 CEL 3.0 MB
EGAF00003952943 CEL 3.0 MB
EGAF00003952946 CEL 3.0 MB
EGAF00003952957 CEL 3.0 MB
EGAF00003952962 CEL 3.0 MB
EGAF00003952964 CEL 3.0 MB
EGAF00003952971 CEL 3.0 MB
EGAF00003952978 CEL 3.0 MB
EGAF00003952988 CEL 3.0 MB
EGAF00003952989 CEL 3.0 MB
EGAF00003952993 CEL 3.0 MB
EGAF00003952998 CEL 3.0 MB
EGAF00003952999 CEL 3.0 MB
EGAF00003953006 CEL 3.0 MB
EGAF00003953008 CEL 3.0 MB
EGAF00003953012 CEL 3.0 MB
EGAF00003953014 CEL 3.0 MB
EGAF00003953018 CEL 3.0 MB
EGAF00003953022 CEL 3.0 MB
EGAF00003953023 CEL 3.0 MB
EGAF00003953026 CEL 3.0 MB
EGAF00003953029 CEL 3.0 MB
EGAF00003953033 CEL 3.0 MB
EGAF00003953034 CEL 3.0 MB
EGAF00003953038 CEL 3.0 MB
EGAF00003953039 CEL 3.0 MB
EGAF00003953048 CEL 3.0 MB
EGAF00003953050 CEL 3.0 MB
EGAF00003953054 CEL 3.0 MB
EGAF00003953064 CEL 3.0 MB
EGAF00003953066 CEL 3.0 MB
EGAF00003953067 CEL 3.0 MB
EGAF00003953074 CEL 3.0 MB
EGAF00003953075 CEL 3.0 MB
EGAF00003953086 CEL 3.0 MB
EGAF00003953091 CEL 3.0 MB
EGAF00003953096 CEL 3.0 MB
EGAF00003953104 CEL 3.0 MB
EGAF00003953106 CEL 3.0 MB
EGAF00003953113 CEL 3.0 MB
EGAF00003953115 CEL 3.0 MB
EGAF00003953118 CEL 3.0 MB
EGAF00003953119 CEL 3.0 MB
EGAF00003953122 CEL 3.0 MB
EGAF00003953123 CEL 3.0 MB
EGAF00003953125 CEL 3.0 MB
EGAF00003953126 CEL 3.0 MB
EGAF00003953130 CEL 3.0 MB
EGAF00003953135 CEL 3.0 MB
EGAF00003953136 CEL 3.0 MB
EGAF00003953137 CEL 3.0 MB
EGAF00003953139 CEL 3.0 MB
EGAF00003953147 CEL 3.0 MB
EGAF00003953149 CEL 3.0 MB
EGAF00003953151 CEL 3.0 MB
EGAF00003953155 CEL 3.0 MB
EGAF00003953157 CEL 3.0 MB
EGAF00003953158 CEL 3.0 MB
EGAF00003953160 txt 2.3 MB
EGAF00003953161 CEL 3.0 MB
EGAF00003953168 CEL 3.0 MB
EGAF00003953169 CEL 3.0 MB
EGAF00003953170 CEL 3.0 MB
EGAF00003953176 CEL 3.0 MB
EGAF00003953177 CEL 3.0 MB
EGAF00003953181 CEL 3.0 MB
EGAF00003953191 CEL 3.0 MB
EGAF00003953192 CEL 3.0 MB
EGAF00003953198 CEL 3.0 MB
EGAF00003953204 CEL 3.0 MB
EGAF00003953208 CEL 3.0 MB
EGAF00003953213 CEL 3.0 MB
EGAF00003953226 CEL 3.0 MB
EGAF00003953232 CEL 3.0 MB
EGAF00003953239 CEL 3.0 MB
EGAF00003953245 CEL 3.0 MB
EGAF00003953246 CEL 3.0 MB
EGAF00003953253 CEL 3.0 MB
EGAF00003953257 CEL 3.0 MB
EGAF00003953264 CEL 3.0 MB
EGAF00003953270 CEL 3.0 MB
EGAF00003953273 CEL 3.0 MB
EGAF00003953279 CEL 3.0 MB
EGAF00003953281 CEL 3.0 MB
EGAF00003953282 CEL 3.0 MB
EGAF00003953283 CEL 3.0 MB
EGAF00003953288 CEL 3.0 MB
EGAF00003953290 CEL 3.0 MB
EGAF00003953293 CEL 3.0 MB
EGAF00003953299 CEL 3.0 MB
EGAF00003953306 CEL 3.0 MB
EGAF00003953310 CEL 3.0 MB
EGAF00003953315 CEL 3.0 MB
EGAF00003953334 CEL 3.0 MB
EGAF00003953337 CEL 3.0 MB
EGAF00003953340 CEL 3.0 MB
EGAF00003953341 CEL 3.0 MB
EGAF00003953342 CEL 3.0 MB
EGAF00003953346 CEL 3.0 MB
EGAF00003953348 CEL 3.0 MB
EGAF00003953353 CEL 3.0 MB
EGAF00003953359 CEL 3.0 MB
EGAF00003953363 CEL 3.0 MB
EGAF00003953364 CEL 3.0 MB
EGAF00003953367 CEL 3.0 MB
EGAF00003953370 CEL 3.0 MB
EGAF00003953375 CEL 3.0 MB
EGAF00003953381 CEL 3.0 MB
EGAF00003953386 CEL 3.0 MB
EGAF00003953390 CEL 3.0 MB
EGAF00003953404 CEL 3.0 MB
EGAF00003953407 CEL 3.0 MB
EGAF00003953409 CEL 3.0 MB
EGAF00003953411 CEL 3.0 MB
EGAF00003953425 CEL 3.0 MB
EGAF00003953428 CEL 3.0 MB
139 Files (410.3 MB)